ホーム › 動脈硬化 › テキサス

テキサスにおける動脈硬化の臨床試験

テキサス内の拠点で、動脈硬化に関する11件の研究が参加者を募集しています。

テキサス内の都市

公式研究テキスト（英語）

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Horizon Clinical Research Group, Cypress
Cardiovascular Specialists of Willowbrook, Houston
Texas Cardiology Associates of Houston, Kingwood
他2件

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

Southwest Family Medicine Associates, Dallas
East Texas Cardiology PA, Houston
Cardiovascular Specialists of Willowbrook, Houston
他1件

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/29更新 · NCT07448038

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

PharmaTex Research, Amarillo
St. David's Heart & Vascular PLLC dba Austin Heart, Austin
Velocity Clinical Research, Austin, Austin
他18件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/24更新 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

PharmaTex Research, LLC, Amarillo
Austin Heart, Austin
Velocity Clinical Research - Austin, Austin
他22件

被験者募集中第3相

45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

PharmaTex Research, LLC, Amarillo
Pulse Care Heart and Vascular, Carrollton
DM Clinical Research - Dallas, Tomball

被験者募集中第2相

18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07521007

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Cussimanio Research Group LLC, Austin
Research Management, Inc., Austin
MW Clinical Research Center, Beaumont
他22件

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/21更新 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Research Site, Amarillo
Research Site, Beaumont
Research Site, Brownsville
他33件

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/24更新 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

PharmaTex Research LLC, Amarillo
Kelsey Seybold Research Foundation, Houston
Northwest Houston Clinical Research PLLC, Tomball

被験者募集中第3相

18歳〜80歳 · 全性別 · 2026/08/07更新 · NCT06813911

Pelacarsen Roll-over Extension Program

Plano Primary Care Clinic, Allen
Pharma Tex Research, Amarillo
SW Family Medicine Associates, Dallas
他8件

被験者募集中第3相

18歳〜100歳 · 全性別 · 2026/07/29更新 · NCT06875973

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

UT Health Houston, Houston

被験者募集中第2相

40歳以上 · 全性別 · 2025/12/17更新 · NCT05488431

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Michael E. DeBakey VA Medical Center, Houston, TX, Houston

被験者募集中第4相

18歳以上 · 全性別 · 2025/12/17更新 · NCT02915198

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。